Literature DB >> 24289581

Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells.

Mei Li1, Xiao-Gang Jiang, Zhen-Lun Gu, Zu-Bin Zhang.   

Abstract

THis study was conducted to analyze the molecular mechanisms responsible for anti-proliferation effects of glaucocalyxin A in cultured MCF-7 and Hs578T breast cancer cells. The concentration that reduced cell viability to 50% (IC50) after 72 h treatment was derived and potential molecular mechanisms of anti-proliferation using the IC50 were investigated as changes in cell cycle arrest and apoptosis. Gene and protein expression changes related to apoptosis were investigated by semi-quantitative RT-PCR and western blotting, respectively. Involvement of phosphorylated mitogen-activated protein kinases and JNK signaling in regulation of these molecules was characterized by western blotting. Cell viability decreased in a concentration-dependent manner and the IC50 was determined as 1 μM in MCF-7 and 4 μM in Hs578T cell. Subsequently, we demonstrated that the GLA-induced MCF-7 and Hst578T cell death was due to cell cycle arrest at the G2/M transition and was associated with activation of the c-jun N-terminal kinase (JNK) pathway. We conclude that GLA has the potential to inhibit the proliferation of human breast cancer cells through the JNK pathway and suggest its application forthe effective therapy for patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24289581     DOI: 10.7314/apjcp.2013.14.10.5805

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Preparation and antitumor effects of glaucocalyxin A-γ-cyclodextrin clathrate.

Authors:  Chong Zhang; Yan Qu; Yan-Long Jia; Xiao-Jun Shang; Su-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Comparative transcriptome analysis of roots, stems and leaves of Isodon amethystoides reveals candidate genes involved in Wangzaozins biosynthesis.

Authors:  Fenglan Zhao; Mengchu Sun; Wanjun Zhang; Chunli Jiang; Jingtong Teng; Wei Sheng; Mingzhi Li; Aimin Zhang; Yongbo Duan; Jianping Xue
Journal:  BMC Plant Biol       Date:  2018-11-08       Impact factor: 4.215

3.  Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway.

Authors:  Mei Li; Cailong Chen; Qian Wang; Xiaolu Jiang; Lanlan Tan; Ying Huang; Yan Zhang; Zubin Zhang
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

4.  Glaucocalyxin A Inhibits the Malignant Progression of Epithelial Ovarian Cancer by Affecting the MicroRNA-374b-5p/HMGB3/Wnt-β-Catenin Pathway Axis.

Authors:  Feng Chen; Fang Sun; Xia Liu; Jing Shao; Bei Zhang
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

5.  Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway.

Authors:  Jianwei Zhu; Yang Sun; Ying Lu; Xiubo Jiang; Bo Ma; Lisha Yu; Jie Zhang; Xiaochen Dong; Qi Zhang
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469

6.  Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.

Authors:  Wenfeng Lin; Jinlin Xie; Naijin Xu; Linglong Huang; Abai Xu; Hulin Li; Chaoming Li; Yubo Gao; Masami Watanabe; Chunxiao Liu; Peng Huang
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

Review 7.  Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer ent-Kaurane Diterpenes.

Authors:  Md Shahid Sarwar; Yi-Xuan Xia; Zheng-Ming Liang; Siu Wai Tsang; Hong-Jie Zhang
Journal:  Biomolecules       Date:  2020-01-16

8.  Glaucocalyxin B inhibits cartilage inflammatory injury in rheumatoid arthritis by regulating M1 polarization of synovial macrophages through NF-κB pathway.

Authors:  Chenyang Han; Yi Yang; Yongjia Sheng; Jin Wang; Xiaohong Zhou; Wenyan Li; Li Guo; Caiqun Zhang; Qiao Ye
Journal:  Aging (Albany NY)       Date:  2021-09-27       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.